RNA Canada ARN Education Series | Perspectives on RNA: Nucleic Acid Therapeutics and Delivery

RNA Canada ARN Education Series

Perspectives on RNA: Nucleic Acid Therapeutics and Delivery

Date: Monday, November 17th
Time: 3:00–4:30 PM EST / 12:00–1:30 PM PST

Overview

This session will highlight recent advances in RNA-based therapeutics, featuring presentations from leading experts in the field.

Featured Speakers

Elisabeth Gardiner, Ph.D. — Chief Scientific Officer, Tevard Biosciences
The use of therapeutic suppressor tRNAs for the treatment of inherited myopathies
(10-minute talk)

Michelle L. Hastings, Ph.D. — Professor, University of Michigan
Zebronkysen: Advancing a Personalized Antisense Oligonucleotide Therapy for CLN3 Batten Disease from Discovery to the Clinic
(10-minute talk)

Omar F. Khan, Ph.D. — Assistant Professor, University of Toronto
Dark transcriptome medicines and antivirals: unexpected but effective RNA applications
(10-minute talk)

Panel Discussion

A ~45-minute panel discussion will follow the presentations.

Registration

Register in advance for this meeting: 
https://us06web.zoom.us/meeting/register/NxH8lYmaRS2ZtdNpXuH_Kg